XENIA PHARMA ApS: Financial statements 2017
CVR: 35529454
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
XENIA PHARMA ApS (CVR 35529454) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -3,444 and a net result of DKK -3,444 compared with DKK -47,265 the year before. Equity in the 2017 report amounted to DKK 29,176. The solvency ratio was 53.5%.
- Gross Profit
- DKK -3,444
- Profit/Loss
- DKK -3,444
- Equity
- DKK 29,176
- Total Assets
- DKK 54,558
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -3K | -3K | 29K | - |
| 2016 | - | -47K | -47K | 33K | 0 |
| 2015 | 103K | 31K | 23K | 80K | - |
Official annual report
Keep an eye on XENIA PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
XENIA PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -47,265, and the net result was DKK -47,265.
About XENIA PHARMA ApS
XENIA PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company is registered under the industry Dyrlægeaktiviteter. The management consists of Dorte Xenia Gram. The company is owned by Dorte Xenia Gram. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -28,827 and a net result of DKK -28,855 compared with DKK -18,952 the year before. Equity in the 2025 report amounted to DKK -46,501.